Exelixis | EXEL - EPS Earnings Per Share


Exelixis reported $0.97 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.76 0.62 May/06
FY2025Q4 Dec/2025 0.97 0.76 0.55 Feb/10
FY2025Q3 Sep/2025 0.78 0.68 0.47 Nov/04
FY2025Q2 Jun/2025 0.75 0.64 0.84 Jul/28
FY2025Q1 Mar/2025 0.62 0.37 0.17 May/13




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Bayer EUR 0.62 0.05 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Exelixis USD 0.97 0.19 Dec/2025
Genmab DKK 3.69 2.77 Dec/2025
Glaxosmithkline GBP 0.21 0.51 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sanofi EUR -0.67 3.62 Dec/2025
Takeda JPY 65.74 73.57 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Xencor USD -0.09 0.01 Dec/2025